<DOC>
	<DOC>NCT02737124</DOC>
	<brief_summary>Patients that are to undergo isolated meniscectomy will be randomized to 2 cohorts: one will take the FDA recommended dose of acetominophen (1000mg) 24hrs before surgery, one will be given a similarly looking placebo pill. A multitude of post-op variables will be included, mainly pain scores and morphine equivalent doses at different time points.</brief_summary>
	<brief_title>Acetaminophen Randomized Controlled Trial</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Must be at least 18 years of age ASA Class III Patients scheduled for meniscectomy Contraindication to acetaminophen (hypersensitivity, extensive alcohol history, liver disease, actively breastfeeding) Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.) Younger than 18 years of age or older than 65 Any patient considered a vulnerable subject Patients on pain medication prior to surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acetaminophen</keyword>
	<keyword>Surgery</keyword>
	<keyword>Meniscectomy</keyword>
</DOC>